294 related articles for article (PubMed ID: 34221399)
21. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.
McBrien CN; Menzies-Gow A
Drugs Today (Barc); 2018 Feb; 54(2):93-101. PubMed ID: 29637936
[TBL] [Abstract][Full Text] [Related]
22. Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis.
Pradhan RR; Nepal G; Mandal S
Pulm Med; 2019; 2019():4376380. PubMed ID: 30941214
[TBL] [Abstract][Full Text] [Related]
23. Mepolizumab as a glucocorticoid-sparing agent in eosinophilic granulomatosis with polyangiitis (EGPA): is a lower dose sufficient?
Vergles M; Matković Z; Lalić K; Trkanjec JT; Tudorić N
J Asthma; 2021 Dec; 58(12):1675-1679. PubMed ID: 32962455
[TBL] [Abstract][Full Text] [Related]
24. Sinonasal and respiratory outcomes of eosinophilic granulomatosis with polyangiitis patients receiving 100 mg mepolizumab in real-life clinical practice: 1-year follow up study.
Can Bostan O; Duran E; Tuncay G; Cihanbeylerden M; Karadag O; Damadoglu E; Karakaya G; Kalyoncu AF
J Asthma; 2023 May; 60(5):931-937. PubMed ID: 35912568
[No Abstract] [Full Text] [Related]
25. Real-world characteristics of "super-responders" to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.
Portacci A; Campisi R; Buonamico E; Nolasco S; Pelaia C; Crimi N; Benfante A; Triggiani M; Spadaro G; Caiaffa MF; Scioscia G; Detoraki A; Valenti G; Papia F; Tomasello A; Scichilone N; Pelaia G; Crimi C; Carpagnano GE
ERJ Open Res; 2023 Sep; 9(5):. PubMed ID: 37908397
[TBL] [Abstract][Full Text] [Related]
26. Benralizumab for eosinophilic granulomatosis with polyangiitis.
Cottu A; Groh M; Desaintjean C; Marchand-Adam S; Guillevin L; Puechal X; Beaumesnil S; Lazaro E; Samson M; Taille C; Durel CA; Diot E; Nicolas S; Guilleminault L; Ebbo M; Cathebras P; Dupin C; Yildiz H; Belfeki N; Pugnet G; Chauvin P; Jouneau S; Lifermann F; Martellosio JP; Cottin V; Terrier B;
Ann Rheum Dis; 2023 Dec; 82(12):1580-1586. PubMed ID: 37550002
[TBL] [Abstract][Full Text] [Related]
27. Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.
Ennis D; Lee JK; Pagnoux C
Expert Opin Biol Ther; 2019 Jul; 19(7):617-630. PubMed ID: 31146595
[TBL] [Abstract][Full Text] [Related]
28. Significant improvement in lung function and asthma control after benralizumab treatment for severe refractory eosinophilic asthma.
Menzella F; Ruggiero P; Galeone C; Scelfo C; Bagnasco D; Facciolongo N
Pulm Pharmacol Ther; 2020 Oct; 64():101966. PubMed ID: 33039666
[TBL] [Abstract][Full Text] [Related]
29. Improvement of peripheral neuropathy in a patient with antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis by additional mepolizumab.
Kai Y; Yoshikawa M; Matsuda M; Suzuki K; Ohara H; Iguchi N; Kasamatsu T; Uno K; Fujioka N; Fujita Y; Muro S
Allergy Asthma Clin Immunol; 2022 Feb; 18(1):14. PubMed ID: 35183225
[TBL] [Abstract][Full Text] [Related]
30. Eosinophilic Granulomatosis with Polyangiitis: Latest Findings and Updated Treatment Recommendations.
Watanabe R; Hashimoto M
J Clin Med; 2023 Sep; 12(18):. PubMed ID: 37762936
[TBL] [Abstract][Full Text] [Related]
31. A rare case report of polyangiitis overlap syndrome: granulomatosis with polyangiitis and eosinophilic granulomatosis with polyangiitis.
Quan MV; Frankel SK; Maleki-Fischbach M; Tan LD
BMC Pulm Med; 2018 Nov; 18(1):181. PubMed ID: 30497438
[TBL] [Abstract][Full Text] [Related]
32. EGPA: Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) as a special presentation of chronic rhinosinusitis with nasal polyps (CRSwNP).
Hagemann J; Laudien M; Becker S; Cuevas M; Klimek F; Kianfar R; Casper I; Klimek L
Allergol Select; 2024; 8():18-25. PubMed ID: 38549809
[TBL] [Abstract][Full Text] [Related]
33. Coexistence of Eosinophilic Granulomatosis With Polyangiitis and Allergic Bronchopulmonary Aspergillosis: A Fascinating Relationship.
Marra AM; Curci P; Franco G; Pittalis G; Tugnoli E; Cavasin D; Cristiano A; Bini F
Cureus; 2024 Apr; 16(4):e57917. PubMed ID: 38601813
[TBL] [Abstract][Full Text] [Related]
34. Switching from omalizumab to mepolizumab therapy improved extra-pulmonary abdominal and cutaneous vasculitis symptoms in a patient with eosinophilic granulomatosis with polyangiitis.
Chen YH; Kuo PH
Respirol Case Rep; 2022 Jan; 10(1):e0878. PubMed ID: 34876987
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of Low-Dose Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Real-Life Experience.
Özdel Öztürk B; Yavuz Z; Aydın Ö; Mungan D; Sin BA; Demirel YS; Bavbek S
Int Arch Allergy Immunol; 2022; 183(12):1281-1290. PubMed ID: 36126640
[TBL] [Abstract][Full Text] [Related]
36. Combination of monoclonal antibodies targeting type 2 inflammation for severe asthma and eosinophilic granulomatosis with polyangiitis.
Davanzo F; Marchi MR; Iorio L; Bortoli M; Doria A; Padoan R
Autoimmun Rev; 2024 Mar; 23(3):103503. PubMed ID: 38101691
[TBL] [Abstract][Full Text] [Related]
37. Nasal polyps in eosinophilic granulomatosis with polyangiitis: Structured histopathology and CD105 expression.
Brescia G; Padoan R; Schiavon F; Contro G; Parrino D; Tealdo G; Felicetti M; Frigo AC; Alessandrini L; Marioni G
Am J Otolaryngol; 2020; 41(6):102661. PubMed ID: 32810787
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil infiltrates and eosinophil aggregates in chronic rhinosinusitis with nasal polyps and EGPA.
Contro G; Brescia G; Alessandrini L; Barion U; Padoan R; Frigo AC; Schiavon F; Marioni G
Clin Rheumatol; 2021 May; 40(5):1949-1957. PubMed ID: 33094393
[TBL] [Abstract][Full Text] [Related]
39. Update on eosinophilic granulomatosis with polyangiitis.
Furuta S; Iwamoto T; Nakajima H
Allergol Int; 2019 Oct; 68(4):430-436. PubMed ID: 31266709
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of clinical benefit from treatment with mepolizumab for patients with eosinophilic granulomatosis with polyangiitis.
Steinfeld J; Bradford ES; Brown J; Mallett S; Yancey SW; Akuthota P; Cid MC; Gleich GJ; Jayne D; Khoury P; Langford CA; Merkel PA; Moosig F; Specks U; Weller PF; Wechsler ME
J Allergy Clin Immunol; 2019 Jun; 143(6):2170-2177. PubMed ID: 30578883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]